138 related articles for article (PubMed ID: 16951535)
1. X-ray irradiation altered chemosensitivity of a p53-null non-small cell lung cancer cell line.
Tsutsumi K; Yasuda M; Nishioka T
Cell Struct Funct; 2006; 31(2):47-52. PubMed ID: 16951535
[TBL] [Abstract][Full Text] [Related]
2. The p53-53BP1-Related Survival of A549 and H1299 Human Lung Cancer Cells after Multifractionated Radiotherapy Demonstrated Different Response to Additional Acute X-ray Exposure.
Pustovalova M; Alhaddad L; Smetanina N; Chigasova A; Blokhina T; Chuprov-Netochin R; Osipov AN; Leonov S
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32397297
[TBL] [Abstract][Full Text] [Related]
3. The CD44high Subpopulation of Multifraction Irradiation-Surviving NSCLC Cells Exhibits Partial EMT-Program Activation and DNA Damage Response Depending on Their p53 Status.
Pustovalova M; Alhaddad L; Blokhina T; Smetanina N; Chigasova A; Chuprov-Netochin R; Eremin P; Gilmutdinova I; Osipov AN; Leonov S
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33673439
[TBL] [Abstract][Full Text] [Related]
4. Δ133p53 decreases the chemosensitivity of carcinoma cell line H1299.
Liu K; Lin J
Cell Biol Int; 2019 Aug; 43(8):960-964. PubMed ID: 31115944
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of Merm1/Wbscr22 attenuates sensitivity of H460 non-small cell lung cancer cells to SN-38 and 5-FU without alteration to p53 expression levels.
Yan D; Zheng X; Tu L; Jia J; Li Q; Cheng L; Wang X
Mol Med Rep; 2015 Jan; 11(1):295-302. PubMed ID: 25352209
[TBL] [Abstract][Full Text] [Related]
6. The tumor suppressor, p53, contributes to radiosensitivity of lung cancer cells by regulating autophagy and apoptosis.
Cheng G; Kong D; Hou X; Liang B; He M; Liang N; Ma S; Liu X
Cancer Biother Radiopharm; 2013 Mar; 28(2):153-9. PubMed ID: 23268708
[TBL] [Abstract][Full Text] [Related]
7. CD44+ and CD133+ Non-Small Cell Lung Cancer Cells Exhibit DNA Damage Response Pathways and Dormant Polyploid Giant Cancer Cell Enrichment Relating to Their p53 Status.
Pustovalova M; Blokhina T; Alhaddad L; Chigasova A; Chuprov-Netochin R; Veviorskiy A; Filkov G; Osipov AN; Leonov S
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563313
[TBL] [Abstract][Full Text] [Related]
8. p53 gene status modulates the chemosensitivity of non-small cell lung cancer cells.
Lai SL; Perng RP; Hwang J
J Biomed Sci; 2000; 7(1):64-70. PubMed ID: 10644891
[TBL] [Abstract][Full Text] [Related]
9. Mutant p53 confers chemoresistance in non-small cell lung cancer by upregulating Nrf2.
Tung MC; Lin PL; Wang YC; He TY; Lee MC; Yeh SD; Chen CY; Lee H
Oncotarget; 2015 Dec; 6(39):41692-705. PubMed ID: 26497680
[TBL] [Abstract][Full Text] [Related]
10. WP1130 attenuates cisplatin resistance by decreasing P53 expression in non-small cell lung carcinomas.
Wang X; Bao Y; Dong Z; Chen Q; Guo H; Ziang C; Shao J
Oncotarget; 2017 Jul; 8(30):49033-49043. PubMed ID: 28446729
[TBL] [Abstract][Full Text] [Related]
11. Enhanced induction of Bax gene expression in H460 and H1299 cells with the combined treatment of cisplatin and adenovirus mediated wt-p53 gene transfer.
Choi JH; Ahn KS; Kim J; Hong YS
Exp Mol Med; 2000 Mar; 32(1):23-8. PubMed ID: 10762058
[TBL] [Abstract][Full Text] [Related]
12. Reduction of microRNA-184 by E6 oncoprotein confers cisplatin resistance in lung cancer via increasing Bcl-2.
Tung MC; Lin PL; Cheng YW; Wu DW; Yeh SD; Chen CY; Lee H
Oncotarget; 2016 May; 7(22):32362-74. PubMed ID: 27083050
[TBL] [Abstract][Full Text] [Related]
13. Transcriptomic Analysis of DNA Repair Pathways in Human Non-Small Cell Lung Cancer Cells Surviving Multifraction X-Ray Irradiation.
Pustovalova MV; Guryanova AA; Sorokin MI; Suntsova MV; Buzdin AA; Alhaddad L; Osipov AN; Leonov SV
Bull Exp Biol Med; 2022 Aug; 173(4):454-458. PubMed ID: 36058984
[TBL] [Abstract][Full Text] [Related]
14. Promotion of p53 expression and reactive oxidative stress production is involved in zerumbone-induced cisplatin sensitization of non-small cell lung cancer cells.
Hu Z; Zeng Q; Zhang B; Liu H; Wang W
Biochimie; 2014 Dec; 107 Pt B():257-62. PubMed ID: 25220870
[TBL] [Abstract][Full Text] [Related]
15. Intracytoplasmic epidermal growth factor receptor shows poor response to the cetuximab antitumor effect in irradiated non-small cell lung cancer cell lines.
Ryu SH; Lee SW; Yang YJ; Song SY; Kim JH; Choi EK; Ahn SD
Lung Cancer; 2012 Sep; 77(3):482-7. PubMed ID: 22704525
[TBL] [Abstract][Full Text] [Related]
16. Differential apoptotic effects of novel quinuclidinone analogs 8a and 8b in normal and lung cancer cell lines.
Malki A; Bergmeier S
Anticancer Res; 2011 Apr; 31(4):1345-57. PubMed ID: 21508385
[TBL] [Abstract][Full Text] [Related]
17. The USP10-HDAC6 axis confers cisplatin resistance in non-small cell lung cancer lacking wild-type p53.
Hu C; Zhang M; Moses N; Hu CL; Polin L; Chen W; Jang H; Heyza J; Malysa A; Caruso JA; Xiang S; Patrick S; Stemmer P; Lou Z; Bai W; Wang C; Bepler G; Zhang XM
Cell Death Dis; 2020 May; 11(5):328. PubMed ID: 32382008
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of Meg3 enhances cisplatin resistance of lung cancer cells through activation of the WNT/β-catenin signaling pathway.
Xia Y; He Z; Liu B; Wang P; Chen Y
Mol Med Rep; 2015 Sep; 12(3):4530-4537. PubMed ID: 26059239
[TBL] [Abstract][Full Text] [Related]
19. [Effect of inhibiting the expression of hSMG-1 on chemosensitivity of human non-small cell lung cancer H1299 cells].
Xia QS; Li YZ; Li HY; Liu X; Xu B; Xiang Q; Yu CY; Chen ZH
Zhonghua Yi Xue Za Zhi; 2011 Mar; 91(8):554-9. PubMed ID: 21418860
[TBL] [Abstract][Full Text] [Related]
20. A comparison of the biological effects of 125I seeds continuous low-dose-rate radiation and 60Co high-dose-rate gamma radiation on non-small cell lung cancer cells.
Wang Z; Zhao Z; Lu J; Chen Z; Mao A; Teng G; Liu F
PLoS One; 2015; 10(8):e0133728. PubMed ID: 26266801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
